159 related articles for article (PubMed ID: 16224411)
1. Palliative chemotherapy in patients with salivary gland neoplasms and preliminary reports of 2 recent phase II studies with trastuzumab and gemcitabine.
Haddad R; Posner MR
Clin Adv Hematol Oncol; 2003 Apr; 1(4):226-8. PubMed ID: 16224411
[TBL] [Abstract][Full Text] [Related]
2. Systemic therapy in the palliative management of advanced salivary gland cancers.
Laurie SA; Licitra L
J Clin Oncol; 2006 Jun; 24(17):2673-8. PubMed ID: 16763282
[TBL] [Abstract][Full Text] [Related]
3. Gemcitabine, paclitaxel, and trastuzumab in metastatic breast cancer.
Miller KD; Sisk J; Ansari R; Gize G; Nattam S; Pennington K; Monaco F; Sledge GW
Oncology (Williston Park); 2001 Feb; 15(2 Suppl 3):38-40. PubMed ID: 11252888
[TBL] [Abstract][Full Text] [Related]
4. Gemcitabine and trastuzumab combinations for patients with metastatic breast cancer overexpressing HER2/neu.
Stein S; DeMichele A; Domchek S; Fox K
Clin Breast Cancer; 2004 Jan; 4 Suppl 3():S117-20. PubMed ID: 14754469
[TBL] [Abstract][Full Text] [Related]
5. Gemcitabine combined with paclitaxel or paclitaxel/trastuzumab in metastatic breast cancer.
Sledge GW
Semin Oncol; 2003 Apr; 30(2 Suppl 3):19-21. PubMed ID: 12722021
[TBL] [Abstract][Full Text] [Related]
6. Trastuzumab for the treatment of salivary duct carcinoma.
Limaye SA; Posner MR; Krane JF; Fonfria M; Lorch JH; Dillon DA; Shreenivas AV; Tishler RB; Haddad RI
Oncologist; 2013; 18(3):294-300. PubMed ID: 23429737
[TBL] [Abstract][Full Text] [Related]
7. [Updates on gemcitabine on metastatic breast cancer].
Gligorov J; Selle F; Khalil A; Abbas F; Namer M; Lotz JP
Bull Cancer; 2007; 94 Spec No Actualites():S90-4. PubMed ID: 17845977
[TBL] [Abstract][Full Text] [Related]
8. Gemcitabine-based therapy in pancreas cancer: gemcitabine-docetaxel and other novel combinations.
Jacobs AD
Cancer; 2002 Aug; 95(4 Suppl):923-7. PubMed ID: 12209672
[TBL] [Abstract][Full Text] [Related]
9. Role of gemcitabine in metastatic breast cancer patients: a short review.
Silvestris N; Cinieri S; La Torre I; Pezzella G; Numico G; Orlando L; Lorusso V
Breast; 2008 Jun; 17(3):220-6. PubMed ID: 18037292
[TBL] [Abstract][Full Text] [Related]
10. Sustained response of carcinoma ex pleomorphic adenoma treated with trastuzumab and capecitabine.
Sharon E; Kelly RJ; Szabo E
Head Neck Oncol; 2010 May; 2():12. PubMed ID: 20504363
[TBL] [Abstract][Full Text] [Related]
11. Gemcitabine and trastuzumab in metastatic breast cancer.
O'shaughnessy J
Semin Oncol; 2003 Apr; 30(2 Suppl 3):22-6. PubMed ID: 12722022
[TBL] [Abstract][Full Text] [Related]
12. Phase II trial of gemcitabine plus trastuzumab in metastatic breast cancer patients previously treated with chemotherapy: preliminary results.
O'Shaughnessy J; Vukelja SJ; Marsland T; Kimmel G; Ratnam S; Pippen J
Clin Breast Cancer; 2002 May; 3 Suppl 1():17-20. PubMed ID: 12057040
[TBL] [Abstract][Full Text] [Related]
13. Phase II study of trastuzumab plus gemcitabine in chemotherapy-pretreated patients with metastatic breast cancer.
O'Shaughnessy JA; Vukelja S; Marsland T; Kimmel G; Ratnam S; Pippen JE
Clin Breast Cancer; 2004 Jun; 5(2):142-7. PubMed ID: 15245619
[TBL] [Abstract][Full Text] [Related]
14. [Role of gemcitabine in treatment of metastatic breast cancer].
Latipova DKh; Semiglazova TIu; Filatova LV; Gershanovich ML
Vopr Onkol; 2011; 57(2):139-46. PubMed ID: 21809657
[No Abstract] [Full Text] [Related]
15. Gemcitabine plus cisplatin for the treatment of metastatic breast cancer.
Heinemann V
Clin Breast Cancer; 2002 May; 3 Suppl 1():24-9. PubMed ID: 12057042
[TBL] [Abstract][Full Text] [Related]
16. Role of gemcitabine in the treatment of advanced and metastatic breast cancer.
Heinemann V
Oncology; 2003; 64(3):191-206. PubMed ID: 12697958
[TBL] [Abstract][Full Text] [Related]
17. Gemcitabine, paclitaxel, and trastuzumab in metastatic breast cancer.
Sledge GW
Oncology (Williston Park); 2003 Dec; 17(12 Suppl 14):33-5. PubMed ID: 14768403
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and Safety of Gemcitabine With Trastuzumab and Pertuzumab After Prior Pertuzumab-Based Therapy Among Patients With Human Epidermal Growth Factor Receptor 2-Positive Metastatic Breast Cancer: A Phase 2 Clinical Trial.
Iyengar NM; Smyth LM; Lake D; Gucalp A; Singh JC; Traina TA; DeFusco P; Fornier MN; Goldfarb S; Jhaveri K; Modi S; Troso-Sandoval T; Patil S; Ulaner GA; Jochelson M; Norton L; Hudis CA; Dang CT
JAMA Netw Open; 2019 Nov; 2(11):e1916211. PubMed ID: 31774522
[TBL] [Abstract][Full Text] [Related]
19. Randomized phase II trial of gemcitabine-cisplatin with or without trastuzumab in HER2-positive non-small-cell lung cancer.
Gatzemeier U; Groth G; Butts C; Van Zandwijk N; Shepherd F; Ardizzoni A; Barton C; Ghahramani P; Hirsh V
Ann Oncol; 2004 Jan; 15(1):19-27. PubMed ID: 14679114
[TBL] [Abstract][Full Text] [Related]
20. Preclinical studies of gemcitabine and trastuzumab in breast and lung cancer cell lines.
Hirsch FR; Helfrich B; Franklin WA; Varella-Garcia M; Chan DC; Bunn PA
Clin Breast Cancer; 2002 May; 3 Suppl 1():12-6. PubMed ID: 12057039
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
